Buscar
Procept Biorobotics Corp
PRCTAñadir a la lista de seguimiento
17.585USD
-0.505-2.79%
Horarios del mercado 09/24, 15:23（ET）
1.00BCap. mercado
PérdidaP/E TTM
Acerca de Procept Biorobotics Corp Compañía
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Perfil de Procept Biorobotics Corp
Símbolo de cotizaciónPRCT
Nombre de la empresaProcept Biorobotics Corp
Fecha de salida a bolsaSep 15, 2021
Director ejecutivoWood (Larry L)
Número de empleados756
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 15
Dirección150 Baytech Drive
CiudadSAN JOSE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal95134
Teléfono16502329832
Sitio Webhttps://www.procept-biorobotics.com/
Símbolo de cotizaciónPRCT
Fecha de salida a bolsaSep 15, 2021
Director ejecutivoWood (Larry L)
Ejecutivos de Procept Biorobotics Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
108.48K
-0.34%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
108.48K
-0.34%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
108.48K
-0.34%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
864.94K
+0.38%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
136.03K
+2.44%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Procept Biorobotics Corp?
Los cinco principales accionistas de Procept Biorobotics Corp son: Dr. Frederic H. (Fred) Moll, M.D.
¿Cuántas instituciones poseen acciones de Procept Biorobotics Corp (PRCT)?
A fecha de 2026Q1, 597 instituciones poseen acciones de Procept Biorobotics Corp, con un valor de mercado combinado de aproximadamente 65.01M, lo que representa el 114.22% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1014187.00.
¿Cuál es la mayor fuente de ganancias de Procept Biorobotics Corp?
El 2026Q1, el segmento empresarial Hand pieces and other consumables generó la ganancia más alta para Procept Biorobotics Corp, ascendiendo a 55.20M y representando el 58.41% de la ganancia total.